Drug
Polyethylene Glycol 4000
Polyethylene Glycol 4000: highest development phase Post-Market, developed by Orion Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| Polyethylene glycol 4000 NCT00603681 | Post-Market | Constipation |
Latest
No recent events.
Follow Polyethylene Glycol 4000 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.